219 related articles for article (PubMed ID: 17942559)
1. Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent.
Molina S; Castet V; Pichard-Garcia L; Wychowski C; Meurs E; Pascussi JM; Sureau C; Fabre JM; Sacunha A; Larrey D; Dubuisson J; Coste J; McKeating J; Maurel P; Fournier-Wirth C
J Virol; 2008 Jan; 82(1):569-74. PubMed ID: 17942559
[TBL] [Abstract][Full Text] [Related]
2. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
[TBL] [Abstract][Full Text] [Related]
3. CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells.
Witteveldt J; Evans MJ; Bitzegeio J; Koutsoudakis G; Owsianka AM; Angus AG; Keck ZY; Foung SK; Pietschmann T; Rice CM; Patel AH
J Gen Virol; 2009 Jan; 90(Pt 1):48-58. PubMed ID: 19088272
[TBL] [Abstract][Full Text] [Related]
4. CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection.
Ishibashi M; Morita N; Nomura-Kawaguchi C; Shimizu Y; Wakita T; Esumi M
Arch Virol; 2014 Nov; 159(11):2949-55. PubMed ID: 24965233
[TBL] [Abstract][Full Text] [Related]
5. Diverse CD81 proteins support hepatitis C virus infection.
Flint M; von Hahn T; Zhang J; Farquhar M; Jones CT; Balfe P; Rice CM; McKeating JA
J Virol; 2006 Nov; 80(22):11331-42. PubMed ID: 16943299
[TBL] [Abstract][Full Text] [Related]
6. Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.
Zhao X; Tang ZY; Klumpp B; Wolff-Vorbeck G; Barth H; Levy S; von Weizsäcker F; Blum HE; Baumert TF
J Clin Invest; 2002 Jan; 109(2):221-32. PubMed ID: 11805134
[TBL] [Abstract][Full Text] [Related]
7. Intracellular delivery of serum-derived hepatitis C virus.
Fukuhara T; Tani H; Shiokawa M; Goto Y; Abe T; Taketomi A; Shirabe K; Maehara Y; Matsuura Y
Microbes Infect; 2011 Apr; 13(4):405-12. PubMed ID: 21262370
[TBL] [Abstract][Full Text] [Related]
8. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.
Harris HJ; Farquhar MJ; Mee CJ; Davis C; Reynolds GM; Jennings A; Hu K; Yuan F; Deng H; Hubscher SG; Han JH; Balfe P; McKeating JA
J Virol; 2008 May; 82(10):5007-20. PubMed ID: 18337570
[TBL] [Abstract][Full Text] [Related]
9. Expression of human factors CD81, claudin-1, scavenger receptor, and occludin in mouse hepatocytes does not confer susceptibility to HCV entry.
Hikosaka K; Noritake H; Kimura W; Sultana N; Sharkar MT; Tagawa Y; Uezato T; Kobayashi Y; Wakita T; Miura N
Biomed Res; 2011 Apr; 32(2):143-50. PubMed ID: 21551950
[TBL] [Abstract][Full Text] [Related]
10. In vitro binding of hepatitis C virus to CD81-positive and -negative human cell lines.
Sasaki M; Yamauchi K; Nakanishi T; Kamogawa Y; Hayashi N
J Gastroenterol Hepatol; 2003 Jan; 18(1):74-9. PubMed ID: 12519228
[TBL] [Abstract][Full Text] [Related]
11. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
Zhang J; Randall G; Higginbottom A; Monk P; Rice CM; McKeating JA
J Virol; 2004 Feb; 78(3):1448-55. PubMed ID: 14722300
[TBL] [Abstract][Full Text] [Related]
12. Single-nucleotide variants in human CD81 influence hepatitis C virus infection of hepatoma cells.
Alberione MP; Moeller R; Kirui J; Ginkel C; Doepke M; Ströh LJ; Machtens JP; Pietschmann T; Gerold G
Med Microbiol Immunol; 2020 Aug; 209(4):499-514. PubMed ID: 32322956
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo.
Meuleman P; Hesselgesser J; Paulson M; Vanwolleghem T; Desombere I; Reiser H; Leroux-Roels G
Hepatology; 2008 Dec; 48(6):1761-8. PubMed ID: 19030166
[TBL] [Abstract][Full Text] [Related]
14. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.
Bartosch B; Vitelli A; Granier C; Goujon C; Dubuisson J; Pascale S; Scarselli E; Cortese R; Nicosia A; Cosset FL
J Biol Chem; 2003 Oct; 278(43):41624-30. PubMed ID: 12913001
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus entry and the tetraspanin CD81.
Farquhar MJ; Harris HJ; McKeating JA
Biochem Soc Trans; 2011 Apr; 39(2):532-6. PubMed ID: 21428934
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus utilizes VLDLR as a novel entry pathway.
Ujino S; Nishitsuji H; Hishiki T; Sugiyama K; Takaku H; Shimotohno K
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):188-93. PubMed ID: 26699506
[TBL] [Abstract][Full Text] [Related]
17. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.
Koutsoudakis G; Herrmann E; Kallis S; Bartenschlager R; Pietschmann T
J Virol; 2007 Jan; 81(2):588-98. PubMed ID: 17079281
[TBL] [Abstract][Full Text] [Related]
18. Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81.
Tian ZF; Shen H; Fu XH; Chen YC; Blum HE; Baumert TF; Zhao XP
World J Gastroenterol; 2009 Jan; 15(2):240-4. PubMed ID: 19132776
[TBL] [Abstract][Full Text] [Related]
19. The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry.
Rocha-Perugini V; Lavie M; Delgrange D; Canton J; Pillez A; Potel J; Lecoeur C; Rubinstein E; Dubuisson J; Wychowski C; Cocquerel L
BMC Microbiol; 2009 May; 9():111. PubMed ID: 19476617
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus entry: potential receptors and their biological functions.
Cocquerel L; Voisset C; Dubuisson J
J Gen Virol; 2006 May; 87(Pt 5):1075-1084. PubMed ID: 16603507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
